参考文献/References:
[1] 李毅,吕艳丽,赵越,等.不同组织模式下乳腺癌筛查结果分析[J].中国癌症杂志,2014,24(12):944-950.
LI Y,LYU Y L,ZHAO Y,et al.Preliminary analysis of different organization models of breast cancer screening[J].Chin Oncol,2014,24(12):944-950.
[2] 李玉阳.山东省乳腺疾病调查报告与乳腺癌危险因素分析[D].济南:山东大学,2011.
LI Y Y.The report of breast diseases screening in Shandong province and breast cancer risk factors analysis[D].Jinan:Shandong University,2011.
[3] 唐艳艳.基于成本-效果评价的我国农村妇女乳腺癌筛查策略优化研究[D].武汉:华中科技大学,2019.
TAGN Y Y.A dissertation submitted to huazhong university of science and technology for the degree of master[D].Wuhan:Huazhong University of Science and Technology,2019.
[4] 黄育北,佟仲生,陈可欣,等.《中国女性乳腺癌筛查指南》解读(精简版)[J].中国肿瘤临床,2019,46(9):433-441.
HUANG Y B,TONG Z S,CHEN K X,et al.Interpretation of guideline for breast cancer screening in Chinese women[J].Chin J Clin Oncol,2019,46(9):433-441.
[5] 刘丽媛.乳腺癌危险因素及高危人群评分筛选模型的初步研究[D].济南:山东大学,2010.
LIU L Y.A pilot study on risk factors and risk assessment score screening model for high-risk population of breast cancer[D].Jinan:Shandong University,2010.
[6] 袁剑敏,高玉堂.乳腺癌的危险因素与绝经状态的关系[J].肿瘤,1991,11(5):199-203.
YUAN J M,GAO Y T.Risk factors for breast cancer relates to the menopausal status at diagnosis[J].Tumor,1991,11(5):199-203.
[7] 费安兴,肖新立,游爱平,等.围绝经期妇女性激素水平的变化[J].中国妇幼保健,2003,18(7):406-407.
FEI A X,XIAO X L,YOU A P,et al.Changes in hormone levels in perimenopausal women[J].Mater Child Health Care Chin,2003,18(7):406-407.
[8] VERKASALO P K,THOMUS H V,APPLEBY P N,et al.Circulating levels of sex hormones and their relation to risk factors for breast cancer:a cross-sectional study in l 092 pre and post menopausal women[J].Cancer Causes Control,2001,12(1):47.
[9] STOLL B A.Adiposity as a risk determinant for postmenopausal breast cancer[J].Int Jobes,2000,24:527-533.
[10] 郑艳敏,沈月平,刘银梅,等.中国女性乳腺癌危险因素Meta 分析[J].中国公共卫生,2012,28(12):1645-1648.
ZHEGN Y M,SHEN Y P,LIU Y M,et al.Meta-analysis on the risk factors of breast cancer among Chinese female[J].Chin J Public Health,2012,28(12):1645-1648.
[11] 郝宇,胡珂嘉.绝经前后中国女性BMI与乳腺癌发病关系的剂量-反应meta分析[J].现代预防医学,2017,44(17):3128-3132.
HAO Y,HU K J.Dose-response relationship between BMI and breast cancer in Chinese women before and after menopause:a meta-analysis[J].Modern Prevent Med,2017,44(17):3128-3132.
[12] 张琪,钱云,靳子义,等.超重肥胖与中国女性乳腺癌关系的Meta分析[J].中华预防医学杂志,2013,47(4):358-362.
ZHANG Q,QIAN Y,JIN Z Y,et al.A meta-analysis on overweight,obesity and the risk of breast cancer in Chinese female population[J].Chin J Prevent Med,2013,47(4):358-362.
[13] DAVIDSON T.Abortion and breast cancer:a hard decision made harder[J].Lancet Oncol,2001,2(12):756-758.
[14] 郭雪君,张寅静,梅勇.人工流产与中国女性乳腺癌关联性的荟萃分析[J].医学研究杂志,2014,43(2):120-123.
GUO X J,ZHAGN Y J,MEI Y.A Meta-analysis of the relationship between the breast cancer and induced abortions in China[J].J Med Res,2014,43(2):120-123.
[15] YU Z G,JIA C X,GENG C Z,et al.Risk factors related to female breast cancer in regions of Northeast China:a 1∶3 matched case-control population-based study[J].Chin Med J (Engl),2012,125(5):733-740.
[16] SESTAK I,DISTLER W,DOWSETT M,et al.Effect of body mass index on recurrences in tamoxifen and anastrozole treated women:an exploratory analysis from the ATAC trial[J].Clin Oncol,2010,28(21):3411-3415.
[17] 沈圆圆,潘跃银.肥胖与乳腺癌关系的研究进展[J].临床肿瘤学杂志,2014,19 (1):72-77.
SHEN Y Y,PAN Y Y.Progression of relationship between obesity and breast cancer[J].Chin Clin Oncol,2014,19(1):72-77.
[18] 张柏林,韩彬彬,王翔,等.女性乳腺癌发病危险因素的病例-对照研究[J].癌症进展,2017,15(4):395-398.
ZHAGN B L,HAN B B,WAGN X,et al.A case-control study on risk factors of breast cancer in females[J].Oncol Prog,2017,15(4):395-398.
[19] MORRIS D H,JONES M E,SCHOEMAKER M J,et al.Determinants of age at menarche in the UK:analyses from the breakthrough generations study[J].Br J Cancer,2010,103(11):1760-1764.
相似文献/References:
[1]罗 晶,李婷婷,王 倩,等.液基薄层细胞学检查、人乳头状瘤病毒检测及阴道镜检查在宫颈癌前病变及宫颈癌筛查中的应用价值[J].新乡医学院学报,2021,38(5):427.[doi:10.7683/xxyxyxb.2021.05.006]
LUO Jing,LI Tingting,WANG Qian,et al.Application value of thin-prep cytology test,human papillomavirus test and colposcopy in the screening of cervical precancerous lesions and cervical cancer[J].Journal of Xinxiang Medical University,2021,38(2):427.[doi:10.7683/xxyxyxb.2021.05.006]
[2]魏 策,侯向萍,陈晓东,等.薄层液基细胞学检测联合DNA倍体分析在宫颈癌前病变早期筛查中的价值[J].新乡医学院学报,2016,33(2):130.[doi:10.7683/xxyxyxb.2016.02.013]
WEI Ce,HOU Xiang-ping,CHEN Xiao-dong,et al.Value of thinprep cytology test combined with DNA ploidy analysis on the early screening for cervical precancerous lesion[J].Journal of Xinxiang Medical University,2016,33(2):130.[doi:10.7683/xxyxyxb.2016.02.013]
[3]李 婷.血清胃蛋白酶原和幽门螺杆菌抗体检测在胃癌早期筛查中的应用价值[J].新乡医学院学报,2016,33(10):913.[doi:10.7683/xxyxyxb.2016.10.021]
LI Ting.Value of serum pepsinogen and Helicobacter pylori antibody detection in screening early gastric carcinoma[J].Journal of Xinxiang Medical University,2016,33(2):913.[doi:10.7683/xxyxyxb.2016.10.021]
[4]姜黄,郑丽华,徐小艳,等.细胞外基质金属蛋白酶诱导因子、基质金属蛋白酶-9和赖氨酸去甲基化酶6B在浸润性乳腺癌组织中的表达及其病理诊断价值[J].新乡医学院学报,2024,(2):143.[doi:10.7683/xxyxyxb.2024.02.008]
JIANG Huang,ZHENG Lihua,XU Xiaoyan,et al.Expression and pathological diagnostic value of extracellular matrix metalloproteinase inducer,matrix metalloproteinase-9 and lysine demethylase 6B in invasive breast cancer[J].Journal of Xinxiang Medical University,2024,(2):143.[doi:10.7683/xxyxyxb.2024.02.008]